128 related articles for article (PubMed ID: 3453427)
1. The effect of chronically administered mianserin, 8-hydroxymianserin and desmethylmianserin on the 'open field' behaviour and brain noradrenaline metabolism in the olfactory bulbectomized rat.
Leonard BE; O'Connor WT
Neuropsychobiology; 1987; 18(3):118-21. PubMed ID: 3453427
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus.
O'Connor WT; Leonard BE
Neuropharmacology; 1986 Mar; 25(3):267-70. PubMed ID: 3703175
[TBL] [Abstract][Full Text] [Related]
3. The effect of (+/-)mianserin and its enantiomers on the behavioural hyperactivity of the olfactory-bulbectomized rat.
Jancsár SM; Leonard BE
Neuropharmacology; 1984 Sep; 23(9):1065-70. PubMed ID: 6083502
[TBL] [Abstract][Full Text] [Related]
4. Chronic effects of mianserin on noradrenaline metabolism in the rat brain: evidence for a pre-synaptic alpha-adrenolytic action in vivo.
Fludder JM; Leonard BE
Psychopharmacology (Berl); 1979 Sep; 64(3):329-32. PubMed ID: 41280
[TBL] [Abstract][Full Text] [Related]
5. The effects of chronic lithium chloride administration on some behavioural and immunological changes in the bilaterally olfactory bulbectomized rat.
Cai Song ; Leonard BE
J Psychopharmacol; 1994 Jan; 8(1):40-7. PubMed ID: 22298479
[TBL] [Abstract][Full Text] [Related]
6. Corticosterone, choline acetyltransferase and noradrenaline levels in olfactory bulbectomized rats in relation to changes in passive avoidance acquisition and open field activity.
Broekkamp CL; O'Connor WT; Tonnaer JA; Rijk HW; Van Delft AM
Physiol Behav; 1986; 37(3):429-34. PubMed ID: 3749302
[TBL] [Abstract][Full Text] [Related]
7. Role of central alpha 2-adrenoceptors on the development of muricidal behavior in olfactory bulbectomized rats: effect of alpha 2-adrenoceptor antagonists.
Hong KW; Lee WS; Rhim BY
Physiol Behav; 1987; 39(4):535-9. PubMed ID: 2437601
[TBL] [Abstract][Full Text] [Related]
8. Behavioural and neuropharmacological properties of the dibenzazepines, desipramine and lofepramine: studies on the olfactory bulbectomized rat model of depression.
O'Connor WT; Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(1):41-51. PubMed ID: 3363165
[TBL] [Abstract][Full Text] [Related]
9. Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs.
van Riezen H; Schnieden H; Wren AF
Br J Pharmacol; 1977 Aug; 60(4):521-8. PubMed ID: 907867
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of mianserin and its enantiomers and metabolites on a behavioral screen for antidepressant activity.
Hand TH; Marek GJ; Seiden LS
Psychopharmacology (Berl); 1991; 105(4):453-8. PubMed ID: 1771213
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression.
O'Connor WT; Earley B; Leonard BE
Br J Clin Pharmacol; 1985; 19 Suppl 1():49S-56S. PubMed ID: 2859878
[TBL] [Abstract][Full Text] [Related]
12. Changes in rat brain norepinephrine levels and turnover after olfactory bulbectomy.
Tonnaer JA; Rigter H; Versteeg DH; Nickolson VJ
Brain Res Bull; 1980; 5(6):683-6. PubMed ID: 7470939
[TBL] [Abstract][Full Text] [Related]
13. Postjunctional effects of mianserin and its metabolites on the rat isolated anococcygeus muscle.
Doggrell SA
J Pharm Pharmacol; 1985 Feb; 37(2):116-20. PubMed ID: 2858543
[TBL] [Abstract][Full Text] [Related]
14. Behavioural and neurochemical interactions between chronic reserpine and chronic antidepressants. A possible model for the detection of atypical antidepressants.
Jancsár SM; Leonard BE
Biochem Pharmacol; 1983 May; 32(10):1569-71. PubMed ID: 6134530
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of antidepressant drugs on [3H]dihydroalprenolol and [3H]imipramine ligand recognition sites in olfactory bulbectomized and sham-lesioned rats.
Jesberger JA; Richardson JS
Gen Pharmacol; 1986; 17(3):293-307. PubMed ID: 3013716
[TBL] [Abstract][Full Text] [Related]
16. Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat.
Jancsàr SM; Leonard BE
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):263-9. PubMed ID: 6204359
[TBL] [Abstract][Full Text] [Related]
17. Adrenoreceptor interactions of the enantiomers and metabolites of mianserin: are they responsible for the antidepressant effect?
Pinder RM
Acta Psychiatr Scand Suppl; 1985; 320():1-9. PubMed ID: 2996305
[TBL] [Abstract][Full Text] [Related]
18. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment.
Connor TJ; Harkin A; Kelly JP; Leonard BE
Neuroimmunomodulation; 2000; 7(1):27-35. PubMed ID: 10601816
[TBL] [Abstract][Full Text] [Related]
19. Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.
Nickolson VJ; Wieringa JH; van Delft AM
Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):48-55. PubMed ID: 6287300
[No Abstract] [Full Text] [Related]
20. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas.
Hellweg R; Zueger M; Fink K; Hörtnagl H; Gass P
Neurobiol Dis; 2007 Jan; 25(1):1-7. PubMed ID: 16990008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
